Egle Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Paris
Industry:BiotechHealth services
Business model:B2B
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 46.22M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Egle Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Eyevensys
57%
|
|
![]() |
Synendos Therapeutics
57%
|
|
![]() |
Ori Biotech
57%
|
|
![]() |
Lifebit
57%
|
|
![]() |
CatalYm
57%
|
|
![]() |
Atai Life Sciences
57%
|
|
![]() |
PetMedix
57%
|
|
![]() |
BoneSupport
57%
|
|
![]() |
Muna Therapeutics
57%
|
|
![]() |
Salvia BioElectronics
57%
|
|